Fairfax County, VA, United States of America

John E McClure


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Fairfax County, VA (US) (1981)
  • Fairfax, VA (US) (1982)

Company Filing History:


Years Active: 1981-1982

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of John E McClure

Introduction

John E McClure is a notable inventor based in Fairfax County, Virginia. He has made significant contributions to the field of immunology through his innovative patents. With a total of two patents to his name, McClure's work has had a lasting impact on diagnostic testing and therapeutic monitoring.

Latest Patents

McClure's latest patents include advancements in radioimmunoassays for the polypeptidic thymic hormone thymosin alpha-1. The first patent describes an improved radioimmunoassay that employs a radiolabelled [Tyr^1]-thymosin alpha-1 or [Tyr^1]-desacetylthymosin alpha-1 as a probe, along with an affinity purified thymosin alpha-1 antibody of enhanced selectivity. The second patent outlines an immunoassay for determining thymosin alpha-1 levels in biological fluids, particularly serum. This assay serves as a valuable diagnostic tool for immune deficiency diseases, autoimmune diseases, and neoplastic diseases, while also enabling the monitoring of therapy with thymosin alpha-1 by tracking blood hormone levels.

Career Highlights

Throughout his career, McClure has worked with prestigious institutions, including Washington University and Hoffmann-La Roche Inc. His expertise in immunology and assay development has positioned him as a key figure in the advancement of diagnostic methodologies.

Collaborations

Some of McClure's notable collaborators include Allan L Goldstein and Su-Sun Wang. Their combined efforts have contributed to the success of his innovative projects and patents.

Conclusion

John E McClure's contributions to the field of immunology through his patents have paved the way for improved diagnostic tests and therapeutic monitoring. His work continues to influence the medical community and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…